epithalon 50 mg EPITHALON (50mg)

10.1038/nbt.3330 26 BoboD.RobinsonK

A Category 1 listing only means a compound can be legally prepared by 503A compounding pharmacies it does not make BPC-157 an FDA-approved drug

Statistics cookies collect information anonymously

In 2023, the FDA finalized its reclassification of several peptide compounds including BPC-157, TB-500 (thymosin beta-4), CJC-1295, ipamorelin, and others removing them from the list of bulk drug substances permitted for compounding under Section 503A and 503B of the Food Drug and Cosmetic Act

It was first isolated in 1974 from the cerebral venous blood of rabbits in a sleep state by Monnier and colleagues, making it one of the earlier identified endogenous neuropeptides associated with sleep-wake cycle regulation research